Inventor · disambiguated record
Signe M. Christensen
Also filed as: CHRISTENSEN SIGNE M
10 granted patents·7 pending applications·617 citations·filing 2003–2018
92Inventor score
Files withROCHE INNOVATION CT COPENHAGEN AS8SANTARIS PHARMA AS6CHRISTENSEN SIGNE M1DETLEF SORENSEN MADS1SOERENSEN MADS DETLEF1
Top patents by PatentIndex Score
17 records- 0197US9708614B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2016·Granted Jul 18, 2017·28 cites·36 claims
- 0297US9428534B2Antisense designSANTARIS PHARMA AS·Filed 2013·Granted Aug 30, 2016·46 cites·78 claims
- 0397US7687617B2Oligonucleotides with alternating segments of locked and non-locked nucleotidesSANTARIS PHARMA AS·Filed 2003·Granted Mar 30, 2010·207 cites·26 claims
- 0496US7569575B2Synthesis of locked nucleic acid derivativesSANTARIS PHARMA AS·Filed 2003·Granted Aug 4, 2009·282 cites·8 claims
- 0592US9994850B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Jun 12, 2018·4 cites·19 claims
- 0689US9045518B2Amino-LNA, thio-LNA and alpha-L-oxy-LNCHRISTENSEN SIGNE M·Filed 2003·Granted Jun 2, 2015·19 cites·19 claims
- 0785US8492390B2Synthesis of locked nucleic acid derivativesDETLEF SORENSEN MADS·Filed 2011·Granted Jul 23, 2013·16 cites·8 claims
- 0884US8084458B2Synthesis of locked nucleic acid derivativesSOERENSEN MADS DETLEF·Filed 2009·Granted Dec 27, 2011·15 cites·13 claims
- 0972US2018237777A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 1071US9951333B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Apr 24, 2018·0 cites·30 claims
- 1171US9890383B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Feb 13, 2018·0 cites·30 claims
- 1270US2014128591A1Antisense designSANTARIS PHARMA AS·Filed 2013·Application pending·0 cites
- 1370US2018237778A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 1468US2014194614A1Amino-lna, thio-lna and alpha-l-oxy-lnSANTARIS PHARMA AS·Filed 2013·Application pending·0 cites
- 1566US2014128586A1Amino-lna, thio-lna and alpha-l-oxy-lnSANTARIS PHARMA AS·Filed 2013·Application pending·0 cites
- 1666US2016168575A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 1765US2016168576A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →